DVA vs HSTM: fair value comparison
DaVita Inc. and HealthStream, Inc. · Updated 2026-10-19
Both currently screen as undervalued on TickrTrends' Forward Fair Value model. Within Healthcare, DVA currently sits closer to the top of our ranking by discount to fair value. HSTM carries the stronger quality grade.
| DVA | HSTM | |
|---|---|---|
| Verdict | Undervalued | Undervalued |
| Last price | $179.25 | $33.13 |
| 12-month range | $103.87–$240.96 | $19.88–$33.75 |
| Rank by discount to fair value | #29 of 108 Healthcare | #31 of 108 Healthcare |
| Quality grade | C | B |
| Momentum grade | — | B |
| Leverage | Low | Low |
| Margin trend | Contracting | Stable |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Overbought |
| 50/200-day trend | — | Uptrend |
| DCF cross-check | Undervalued | Fairly Valued |
| 52-week position | The upper-middle quarter | The top quarter |
Full single-stock breakdowns: DVA fair value analysis · HSTM fair value analysis